BAUSCH + LOMB CORP.

BLCO06 Dec 2024
Healthcare
$19.7
+0.01 (+0.86%)
Lowest Today
$19.59
Highest Today
$19.95
Today’s Open
$19.7
Prev. Close
$19.74
52 Week High
$21.69
52 Week Low
$13.16
To Invest in BAUSCH + LOMB CORP.

BAUSCH + LOMB CORP.

Healthcare
BLCO06 Dec 2024
+0.01 (+0.86%)
1M
3M
6M
1Y
5Y
Low
$19.59
Day’s Range
High
$19.95
19.59
52 Week Low
$13.16
52-Week Range
52 Week High
$21.69
13.16
1 Day
-
1 Week
+0.7%
1 month return
+0.63%
3 month return
+25.43%
6 month return
+28.7%
1 Year return
+31.42%
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
Maple Rock Capital Partners, Inc.
1.03
ICAHN CARL C
0.99
Goldentree Asset Management LP
0.95
Fidelity Greater Canada Sr F
0.84
Alberta Investment Management Corp
0.63
River Road Asset Management, LLC
0.57
D. E. Shaw & Co LP
0.54

Market Status

Fundamentals
Market Cap
6951.72 mln
PB Ratio
1.05
PE Ratio
0
Enterprise Value
11237 mln
Total Assets
13442 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Organisation
BAUSCH + LOMB CORP.
Employees
13000
Industry
Medical Instruments & Supplies
CEO
Mr. Brenton L.  Saunders J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities